课题基金 / 基金详情

Analyses of the long-term outcomes and prognostic factors of Japanese patients undergoing first coronary revascularization.

Analyses of the long-term outcomes and prognostic factors of Japanese patients undergoing first coronary revascularization.
对接受首次冠状动脉血运重建的日本患者的长期结果和预后因素进行分析。
批准号:
18590771
负责人:
KIMURA Takeshi
金额:
$2.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KIMURA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
一项多中心研究纳入了2000年1月至2002年12月期间连续接受首次PCI或CABG治疗的冠状动脉疾病患者。在入选的9877例患者中,5420例(PCI: 3712例,CABG: 1708例)患有多血管疾病,未累及左主干。本研究比较了5420例可能有CABG指征的患者PCI与CABG的预后。由于年龄是决定血运重建策略的一个非常重要的决定因素,因此还对年龄≥75岁或<75岁的分层亚组进行了生存分析。其他相关亚组也进行了分析。3年时,PCI组(89.6%)和CABG组(91.7%)的未调整生存率相当(log rank p=0.26)。在调整基线特征后,CABG后的生存结果倾向于更好(PCI与CABG后死亡的危险比[HR](95%置信区间[CI]): 1.23 (0.99-1.53), p=0.06)。在75岁以上的CABG患者中(HR (95%CI): 1.37 (0.98-1.92), p= 0.07),但在<75岁的患者中(BR (95%CI): 1.09 (0.82-1.46), p= 0.55), CABG患者的调整生存结果也趋于更好。当老年患者(75岁)被排除在分析之外时,CABG和PCI的未调整和调整生存结局在任何亚组中都没有显著差异。关于任何血运重建手术的自由率,PCI组和CABG组之间存在显著差异。3年后,PCI组中只有51.7%的患者没有进行任何血运重建手术,而CABG组中有90.2%的患者没有进行任何血运重建。因此,<75岁的患者在PCI和CABG后的生存结果相似,而在裸金属支架时代,PCI后的患者经常接受冠状动脉血运重建术。
英文摘要
A multicenter study enrolling consecutive patients with coronary artery disease undergoing first PCI or CABG between January 2000 and December 2002 has been conducted. Patients with acute myocardial infarction within a week have been excluded from enrollment Among the 9,877 patients enrolled, 5,420 (PCI: 3,712, CABG: 1,708) had multivessel disease without left main involvement. The present study compared the prognosis of PCI versus CABG in the 5,420 patient s who have possible indication of CABG. Because age is a very important determinant when deciding revascularization strategies, survival analysis was also performed in the stratified subgroups by either age 〓 75 or <75 years. Analyses were also performed in other relevant subgroups. At 3 years, unadjusted survival rates were comparable between the PCI (89.6%) and CABG (91.7%) groups (log rank p=0.26). After adjustment for baseline characteristics, survival outcome tended to be better after CABG (hazard ratio for death after PCI vs. CABG [HR] (95% confidence interval [CI]): 1.23 (0.99-1.53), p=0.06). Adjusted survival outcomes also tended to be better for CABG among the patients 〓 75 years (HR (95%CI): 1.37 (0.98-1.92), p= 0.07), but not among the patients <75 years (BR (95% CI): 1.09 (0.82-1.46), p= 0.55). Unadjusted and adjusted survival outcome for CABG and PCI were not significantly different in any subgroups when elderly patients ($75 years) were excluded from analysis. In regard to the rate of freedom from any revascularization procedures, there was a striking difference between the PCI and CABG groups. At 3 years, only 51.7% of patients in the PCI group were free from any revascularization procedures as compared with 90.2% of patients in the CABG group.Thus, survival outcomes among patients <75 years of age were similar after PCI and CABG, while the patients after PCI often underwent coronary revascularization procedures in the era of bare metal stent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ChronicObstructive Pulmonary Disease was an Independent Predictor of Sudden Cardiac Death, Cardiac Death and All-cause Mortality after Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting
慢性阻塞性肺疾病是经皮冠状动脉介入治疗和冠状动脉旁路移植术后心源性猝死、心源性死亡和全因死亡的独立预测因素
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Nishiyama, K., Shizuta, S., Taniguchi, R., Ehara, N., Haruna, Y., Abe, M., Toma, M., Furukawa, Y., Kaburagi, S., Doi, O., Kambara, H., Nara, M., Matsuda, K., Hamasaki, S., Tei, C., Yamamoto, H., Sakata, R., Morimoto, T., Imai, Y., Teramukai, S., Fukushima]
通讯作者: Fukushima
Comparison of Percutaneous Coronary Intervention(PCI)and Coronary Artery Bypass Graft Surgery(CABG)in Diabetic Patients(pts)with Multi-Vbssel Coronary Artery Disease in The Bare-Metal Stent(BMS)Era: From The Coronary Revascularization Demonstrating Outcom
裸金属支架(BMS)时代经皮冠状动脉介入治疗(PCI)与冠状动脉搭桥手术(CABG)治疗多血管糖尿病糖尿病患者的比较:来自冠状动脉血运重建的示范结果
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Takeshi, Kimura, M.D., Takeshi Morimoto, M.D., Yutaka, Furukawa, M.D., Yoshihisa, Nakagawa, M.D., Satoshi, Shizuta, M.D., Natsuhiko, Ehara, M.D., Ryoji, Taniguchi, M.D., Takahiro, Doi, M.D., Kei, Nishiyama, M.D., Neiko Ozasa, M.D., Naritatsu, Saito, M.D.,, 静田 聡, 江原 夏彦]
通讯作者: 江原 夏彦
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention is Associated With High Long-Term Mortality : Insights From CREDO-Kyoto Registry
经皮冠状动脉介入治疗后造影剂肾病与高长期死亡率相关:来自 CREDO-Kyoto 登记处的见解
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Abe, M., Taniguchi, R., Ehara, N., Saito, N., Shizuta, S., Furukawa, Y., Okazaki, K., Sakurai, T., Kataoka, K., Ogawa, H., Kawasuji, M., Hirai, T., Maeda, S., Morimoto, T., Teramukai, S., Fukushima, M., Kita, T., Kimura, T]
通讯作者: T
CREDO-Kyoto Investigators Long-Term Clinical Outcome of Percutaneous Coronary Intervention With Bare Metal Stent for Unprotected Left Main Coronary Artery Disease Compared With Bypass Graft Surgery : From the CREDO-Kyoto
CREDO-Kyoto 研究人员使用裸金属支架经皮冠状动脉介入治疗无保护的左主干冠状动脉疾病与搭桥手术的长期临床结果相比:来自 CREDO-Kyoto
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Shizuta, S., Doi, T., Taniguchi, R., Ehara, R., Nishiyama, K., Furukawa, Y., Tatami, R., Ushijima, T., Hattori, R., Nishiwaki, N., Tanaka, M., Minami, K., Sato, Y., Tezuka, S., Morimoto, T., Teramukai, S., Fukushima, M., Kita, T., Kimura, T]
通讯作者: T
共 15 条
    Elucidation of the mechanism of neoatherosclerosis
    • 批准号:
      25293182
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2013
    • 负责人:
      KIMURA Takeshi
    • 依托单位:
    Engaged Research in Constructing Cultural Value for balancing economic development and environmental conservation in light of religious teaching
    • 批准号:
      25580013
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.91万
    • 财政年份:
      2013
    • 负责人:
      KIMURA Takeshi
    • 依托单位:
    New approach to analyze inherited arrhythmias using human iPS cells
    • 批准号:
      24659387
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KIMURA Takeshi
    • 依托单位:
    Structural studies on IL-18 ligand receptor complex for designing new drugs of allergy and autoimmune diseases
    • 批准号:
      21790979
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2009
    • 负责人:
      KIMURA Takeshi
    • 依托单位:
    海外基金